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In this paper  we have focused our attention  on one fundamental  property 
of leucocytes which can be  measured  quantitatively,  namely their  ability  to 
migrate by ameboid motion. This report is part of an integrated study on the 
functions  of  leucocytes  which  has  interested  this  group  for  some  time.  A 
preliminary report  (Ketchel  and  Favour,  1953 a)  indicates  that factors occur 
in  the  plasma  which influence  strongly the  rate  of leucocyte migration.  The 
present paper illuminates  to some degree the nature of these factors, and also 
describes a  new method of measuring leucocyte migration.  In other investiga- 
tions, the method has been found to have considerable usefulness in the study 
of  leucocyte physiology  (Ketchel  and  Favour,  1953 b:  O'Neill  and  Favour, 
1955). 
Methods 
As  shown  diagrammatically  in  Fig.  1,  this  technique  utilizes  a  micro-hematocrit, 
formed inside a capillary tube of the type ordinarily used for melting point determinations. 
The tube is partially filled by capillarity  when one end is held in a blood cell suspension. 
After the other end has been dosed, the tube is centrifuged, resolving the suspension into three 
components; a basal layer of packed erythrocytes, an intermediate layer of leucocytes, and an 
uppermost layer of plasma. Upon incubation of the tube, the leucocytes migrate by ameboid 
motion into the plasma layer. The distance  of migration  is then measured by means of an 
ocular micrometer. The method provides a three-variable system in which the cells, the plasma, 
and any antigen,  hormone, etc.,  may be varied.  Elaborate controls may be included with 
little additional work. This simplicity of experimentation  enables a single worker, in a rela- 
tively short time, to set up enough tubes to permit application  of statistical  methods in the 
analysis of data. 
Glass~vare.--Seven era. lengths of capillary tubing with an internal  diameter of 0.8 4- 0.1 
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ram. were used. Since attempts to clean the capillary tubes by a variety of methods produced 
toxic effects on the cells, new tubes were used for each experiment with no pretreatment except 
sterilization. 
FIo. 1. Diagrammatic representation of the eapiliary tube method of measuring leucocyte 
migration. 
All other glassware was coated with silicone, 1 cleaned thoroughly, and sterilized. Aseptic 
technique was used throughout the preparation of the cell suspensions  and the loading of the 
tubes. 
Cd/s.--Normal healthy  subjects  and  hospitalized  patients  with  various  acute  illnesses 
1 Dryfilm 9987,  General Electric Company, Pittsfield, Mass. R[ELVIN  M.  KETCHEL  AND  CUTTING B.  FAVOUR  649 
served as donors. Ten ml. of venous blood was collected from each donor in syringes containing 
0.5 m]. of a 2 mg./ml, heparin solution.  2 This concentration of heparin was chosen empirically 
as the amount which delayed clotting until the capillary tubes had been filled. Approximately 
5 ml. of blood from each donor was discharged into individual 15  ml. centrifuge tubes and 
promptly centrifuged at 1200 g for 15 minutes. The clear supernatant plasma  fractions  were 
recentrifuged at 1600 g to clear them of platelets, and stored in an ice bath for later use in the 
experiment. 
Each cellular  fraction was then washed three times by successive resuspension and centri- 
fugation in 4 volumes of the balanced salt solution of Hanks and Wallace (1949). While this 
part of the method had as its purpose the freeing of the cells of their autologous  3 plasma for 
experiments in which cells were tested in other plasmas, the procedure was carried out in all 
experiments to permit comparison of data. Storage of cells and subsequent preparation of cell 
suspensions were carried out in an ice bath. 
Preparation of Capillary Tubes.--Following the washing of cells  and  the freeing of the 
plasma of formed elements, cells and plasma were recombined in the proportions indicated in 
the sample protocol (Table IV). The ingredients were adjusted so that the final plasma con- 
centration was half the fluid volume, a plasma dilution which gave a clear, non-retractile clot 
in the capillary tube supernatant. 
The microtubes were then loaded by capillarity to approximately 2/~ their length. The free 
end was promptly sealed in a high temperature flame, and cooled in alcohol. 4 Groups of tubes 
were centrifuged at 1600 g for 1 minute to form the three-phase system indicated in Fig. 1. 
Contact with the glass wall of the capillary tube by the cell suspension induced clotting within 
a minute to an hour or more. Tubes were inspected microscopically following centrifugation, 
and selected for absence of cells on the wall  or in  the plasma and for a  sharp cell-plasma 
boundary. For each combination of cells and plasma 10 capillary tubes were used. With prac- 
tice, it was possible for one person to prepare large numbers of capillary tube cultures within 
3 to 4 hours of the initial venipuncture. 
Cell Migration.--The capillary tubes were incubated vertically at 37°C.  Within 2 hours, 
there appeared above the huffy coat a haze of discrete cells which, when watched individually, 
were seen to be actively migrating along the tube wall or in the plasma clot. These cells formed 
a  zone with an easily discernible boundary. After 16 to  18 hours, the distance between the 
leading edge of this zone and the buff)" coat was measured by means of an ocular micrometer. 
Repeat measurements on  the  same  tube  by  different observers generally  checked  within 
0.10 ram. A few cells were often seen in the plasma beyond the leading edge of the migrating 
zone, but since these cells seemed to be independent of the generalized migration from the 
buffy coat, they were ignored for the purposes of these experiments. The cells composing the 
moving boundary, as well as those with a faster rate of migration, were po]ynuclear cells. 
To facilitate microscopy, groups of capillary tubes were secured at their upper ends to a 
1 ;<  3 inch microscope slide with a  drop of micromount  5 (Fig. 2).  Fig. 3 shows the hourly 
migration of the leucocytes of two subjects with markedly differing migration rates. It can be 
seen that regardless of the migration rate, the migration of the leucocytes ceased at approxi- 
mately the same time in both cell-plasma systems. Accordingly, the results in a given experi- 
2 Liquaemin, Organon, Inc., Orange, New Jersey. 
3 Throughout the present paper the words "autologous" and "homologous" will have the 
usage usually employed by immunologists. Autologous will refer to cells and plasma from the 
same donor, and homologous will refer to cells and plasma from different donors. 
4 Cooling in water may fracture the capillary tubes. 
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ment could be recorded either as the rate of migration in the first phase of the culture, or as 
the distance of migration after a given time. A single measurement at 16 to 18 hours was taken 
as a convenient end-point for the experiments in this study. 
FIG.  2. A group of capillary tubes secured to a  microscope slide to facilitate  microscopy. 
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FIe. 3.  Rate of leucocytes in their own plasmas, as observed in the cases of two different 
subjects. The difference in migration distance is the result of a difference in the rate of migra- 
tion during the early hours of the experiment. 
RESULTS 
Individual  Variation  in Migration.--The  first  series of experiments  (Table 
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were studied repeatedly during a  period of several weeks to several months, 
precautions being taken to avoid periods during which the individual showed 
symptoms of minor seasonal  infections.  The average distances  of leucocyte 
migration of the 7 normal subjects ranged from 0.47 to 2.67 mm. As judged 
by the standard deviations (S.D.), the variations encountered in repeated tests 
on the blood of individual donors were not large for this type of measurement. 
It is apparent that, even though there is a great deal of variation in leucocyte 
migration from individual  to individual,  such normal  healthy subjects show 
relatively little variation in  their leucocyte migration  distance  from day  to 
day. 
Variations among Normal Individuals.--In an effort to determine the normal 
limits of leucocyte migration, a series of 78 normal individuals were each tested 
TABLE I 
Average Migration Distance of Leucocytes from Normal Subjects 
NO. Of ex-  Mean  S.D.  Subject  Sex  Blood type  perlments 
KEK 
MMK 
JQH 
RK 
JL 
LS 
CBF 
F 
M 
F 
F 
M 
F 
M 
A+ 
A+ 
A+ 
O+ 
A+ 
O+ 
O+ 
5 
37 
12 
6 
30 
24 
9 
raM. 
0.47 
0.61 
0.61 
1.35 
1.96 
2.46 
2.67 
fnftt. 
0.21 
0.19 
0.14 
0.45 
0.57 
0.50 
0.52 
from 1 to 3 times. The results are shown in Fig. 4. The subjects were laboratory 
or hospital personnel, medical students, etc., in good health. 
These  results  indicate  that  the  normal  limits  of leucocyte migration  are 
wide. Those subjects  whose leucocytes migrated less  than 0.3  ram.  or more 
than  3.5  mm.  in  the  initial  test,  showed,  on  subsequent  testing,  migration 
rates falling between these limits. Apparently there are factors at work in the 
normal individual which may cause at least an occasional wide fluctuation in 
leucocyte migration. 
While some individuals, such as those indicated in Table I, were shown to 
be consistent from day to day, other individuals could be found in whom wide 
fluctuations  in  migration  distance  were  observed.  Data  from  two  such  in- 
dividuals are presented in Table II. In the light of our later experience with 
subjects  undergoing  symptomatic  respiratory  infections,  as  well  as  more 
serious illnesses, it is interesting that  these two subjects had arrested tuber- 
culosis, one of the spine, and the other of the lungs. 
Neither an individual's day to day variation in leucocyte migration, nor the 652  MIGRATION  OF  LEUCOCYTES  IN  VITRO 
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Fro. 4. Distribution of leucocyte migration distances in a series of 78 normal individuals. 
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FIG. 5. Effect on leucocyte migration of the removal of fibrinogen from the plasma. MELVIN  M. KETCHEL AND  CUTTING B.  FAVOUR  653 
variation among individuals,  could be correlated with the total or differential 
white blood count in whole blood or in the final cell suspension. 
Leucocyte  Migration  during  Illness.--An  endemic  virus-type  respiratory 
illness manifested by coryza, malaise, fever, and mild bronchitis provided an 
opportunity to observe the effects of an infection on the leucocyte migration 
of several of the individuals listed in Table I  who had already been studied 
to some degree. The early phase of these infections was frequently characterized 
by as much as a four- to fivefold increase in leucocyte migration. For a variable 
period  thereafter,  wide  day to  day fluctuations  in  leucocyte migration were 
TABLE  II 
Average Migration  Distances of Leucocytes  from Tuberculous  Sub 'ects 
Subject  Sex  Blood type  No. of ex-  periments  Mean  s.m 
LS  F  A+  32  1.61  0.76 
FM  F  B+  49  1.46  0.65 
TABLE III 
Average Migration Distance of Leucocytes from Hospital Patients 
Subject  Sex  Blood  Disease  Mean  S.D. 
type 
RT 
EC 
JK 
WS 
JB 
SG 
M 
F 
M 
M 
M 
M 
o+ 
o+ 
A-I- 
A+ 
O- 
O- 
Diabetes mellitus 
Bronchitis 
Myocardial infarction 
Cerebrovascular accident 
Bleeding  duodenal  ulcer  with 
pyloric obstruction 
Hyperparathyroidism 
No. of ex- 
periments 
13 
7 
6 
9 
14 
15 
mm. 
1.33 
1.59 
1.68 
2.22 
2.39 
2.84 
0.62 
0.53 
0.76 
0.91 
0.80 
0.39 
observed. These changes did not form a  consistent pattern, and the return to 
normal was often slow. 
Observations  on  more  acute  illnesses  were  made  in  a  group  of  subjects 
hospitalized  for a  variety of disorders  including  infection  and  tissue  insults 
(Table III). Although it was again found that leucocytes of some individuals 
migrated at a  slow rate and others at a  fast rate,  there was distinctly more 
variation in each subject from day to day than was encountered  in  normal 
healthy individuals.  This fact may be seen by a  comparison of the  s.D.'s of 
Table  III (hospital  patients)  with  the  s.D.  of Table  I  (normals).  Since  the 
S.D. is a  function of the amount of variation in a  group of data, a  t  test was 
applied to the s.D.'s of the normal group as compared with  the  s.D.'s of the 654  MIGRATION  O~ LEUCOCYTES  IN VITRO 
hospital  patients  to  evaluate  these  differences in  variation.  The value for t 
is equal  to 3.33,  and p  is less than 0.01.  These results,  coupled with the ob- 
servations  on  normal  subjects  followed  during  the  above  mentioned  virus 
infections,  led  to  the  conclusion  that,  during  illness,  the  migration  rate  is 
more variable than in normal subjects. 
The Effect  of the Plasma  on Leucocyte Migration.--We  have noted in Table 
I  the  striking  differences in  the  average leucocyte migration rate of various 
subjects.  A  series  of experiments was undertaken  to  determine  whether  the 
variability was due to factors residing in the plasma or in the ceils. 
The protocol for these experiments is recorded in Table IV. For each experi- 
ment involving a  "slow" and a  "fast" migrator, 40 capillaries were  prepared. 
TABLE IV 
Sample Protocol Combining  Cell Suspensions in Autologous  or Homologous Plasma 
Subject I cells, cc  ............................. 
Subject II cells, c¢  ........................... 
Subject I plasma, cc  .......................... 
Subject II plasma, c¢  ........................ 
Hanks's solution, cc  ......................... 
Results, mm  ................................ 
Mean  mm  ................................... 
S.D., mm  .................................... 
0.2 
0.3 
0.1 
3.0 
3.6 
3.1 
2.6 
3.9 
2.4 
1.8 
2.7 
2.7 
2.7 
2.8 
0.6 
0.2 
0.3 
0.1 
0.4 
1.4 
0.9 
0.6 
0.4 
0.4 
1.2 
0.8 
1.1 
1.6 
0.9 
0.4 
0.2 
0.3 
0.1 
3.2 
2.0 
2.7 
0.3 
1.9 
0.6 
1.3 
2.7 
2.5 
2.4 
1.9 
[}.8 
0.2 
0.3 
0.1 
0.6 
0.8 
0.4 
0.9 
0.l 
1.0 
1.1 
0.4 
0.7 
0.4 
0.6 
0.3 
10 contained slow cells in slow plasma; 10,  slow cells in fast plasma; 10,  fast 
cells in slow plasma; and  10,  fast cells in fast plasma. The results of a  series 
in which 7 pairs of subjects were studied in this manner in a total of 30 experi- 
ments are shown in Table V. Fast cells in slow plasma migrate almost as slowly 
(1.3  mm.)  as do  slow  cells in  slow plasma  (1.0  mm.)  and  slow  cells in fast 
plasma migrate almost as fast (1.7  mm.) as fast cells in fast plasma (2.2 mm.). 
It can therefore be concluded that while the cells have some influence on the 
migration rate, the major factors influencing cell migration reside in the plasma. 
It should be pointed out, however, that while the majority of the experiments 
indicated  that  cell migration was under  plasma  control,  in  approximately 1 
out  of  15  experiments,  the  reverse seemed  to  be  true.  In  these  unusual  in- 
stances, the major forces affecting cell migration appeared to be in the cells. MELVIN  M.  KETCHEL  AND  CUTTING  B,  I~AVOUR  655 
These  findings  could  not  be  correlated  with  illness,  with  leucocyte  counts 
either  in  the  blood sample as it  was taken from the  patient or used in  the 
experiment, nor with any other discernible cause. 
The Nature of the Plasma Factor.--An  extended series of investigations was 
undertaken  to determine the nature of the plasma factor or factors involved 
in the control of leucocyte migration. 
(a) lsoagglutinins.  In  experiments in  which  the plasma and  cells were ob- 
tained from different individuals, major blood groups were ordinarily matched 
in order  to eliminate isoagglutinins  as a  source  of variability.  In a  series of 
experiments in which this matching was not performed, it was found that the 
plasma factor had  similar  effects on both  autologous  and  homologous  cells. 
TABLE V 
Average Migration Rate of Slew and Fast Calls in A~alogous and Homologous  Plasmas 
Subjects 
Slow  Fast 
MMK  JL 
MMK  IS 
MMK  ES 
FM  LS 
BL  LS 
JQH  LS 
LA  JL 
Blood types 
Slow  Fast 
A+  A+ 
A+  A+ 
A+  O+ 
B+  A+ 
O+  A+ 
A+  A+ 
O+  A+ 
No. of ex- 
periments 
)ver-a]l averages*,  mm  .... 
.D.*  film.. 
Slow cells 
and slow 
plasma 
mfa. 
0.6 
1.1 
0.9 
1.1 
1.2 
1.9 
1.2 
1.0 
0.55 
Fast ceils  Slow cells 
and slow  and fast 
plasma  plasma 
mm.  gtl4~. 
1.0  1.6 
1.7  1.5 
1.2  1.5 
1.1  1.9 
1.5  1.6 
1.5  2.7 
Clotted  1.8 
1.3  1.7 
0.98  0.94 
Fast  cells 
and fast 
plasma 
mm. 
2.1 
2.2 
2.3 
2.1 
1.8 
3.2 
2.2 
2.2 
0.86 
* Obtained by weighting each of the 30 experiments equally. 
It is therefore evident  that  the plasma factor responsible for the rate of cell. 
migration is not an isoagglutinin. 
(b)  Fasting  vs.  Non-Fasting  Blood.  Samples  of  blood  were  taken  before 
breakfast, and 1 hour after breakfast from the same individual. A comparison 
of the migration of prebreakfast cells in prebreakfast plasma with postbreak- 
fast cells in postbreakfast plasma showed that fasting had no detectable effect 
on leucocyte migration under  the conditions of the present  technique. 
(c) Degree  of Clotting.  We have seen  that  leucocytes from various sources 
cultured  in a  given plasma sample tend to migrate at a  similar rate. To test 
the  possibility  that  this  was  the  result  of  a  simple  physical  barrier  in  the 
plasma clot,  samples of blood from a  slow individual  (MMK)  and a  fast in- 
dividual  (JS)  were "whipped," and the serum recovered. Ceils from the slow 
individual  were  cultured  in  slow and  fast serum,  and  cells from the fast in- 656  MIGRATION  O~g LEUCOCYTES  IN VITRO 
dividual were cultured in slow and fast serum.  Except for the substitution of 
serum for plasma, the protocol was the same as that in Table IV. 
In the absence of a  clot,  the leucocytes  migrated along the capillary tube 
walls. The results,  as shown in Table VI, demonstrate that the factors con- 
trolling the rate of leucocyte migration are present in the serum as well as in 
the plasma. 
(d)  The  Suspension  Stability  of the  Blood. The  experiments  of  Fahraeus 
(1929) indicate that the sedimentation rate of erythrocytes is affected by the 
relative  amounts  of  certain plasma  proteins,  especially  fibrinogen,  present 
in the plasma.  Although the  sedimentation of erythrocytes and the  active 
migration of leucocytes are very different phenomena, the possibility presented 
itself that both cell activities might be related. 
Two blood  samples were collected from a  "slow" individual (MMK), and 
two blood samples from a  "fast" individual (JS).  One sample  from each in- 
dividual was heparinized  as usual, and used as a  source of cells and plasma. 
TABLE VI 
Average Migration Distance of Leucocytes Cultured in Slow and Fast Serum 
Serum  MMX  cells  JS celh 
MMK  0.95  i.  15 
JS  2.15  2.35 
The other sample from each individual was "whipped" to remove the fibrino- 
gen. As shown in Fig. 5, fast ceils were tested in fast plasma,  in fast serum, 
and in a mixture of equal parts of fast plasma and fast serum. Slow cells were 
tested in fast plasma,  in fast serum, and in a mixture of fast plasma and fast 
serum. Fast cells were tested in slow plasma, in slow serum, and in a mixture 
of slow plasma and slow serum.  And, slow cells were tested in slow plasma, 
in slow serum, and in a mixture of slow plasma and slow serum. 
As shown in Fig. 5, the removal  of fibrinogen resulted in some change in 
the absolute  migration rate. Relative migration rates remained the same, in- 
dicating that the plasma factors,  which caused cells to migrate faster in one 
plasma than another, were present in serum as well as in plasma. 
(e) Dialysis  and Heating of the Plasma.  Samples of plasma from a  "slow" 
migrator  (MMK)  and  a  "fast" migrator  (JL),  respectively,  were  dialyzed 
at 4°C. for 48 hours against three changes of 1000 volumes of Hanks's solu- 
tion. Dialyzed plasmas  and non-dialyzed  control plasmas  were  then tested 
against slow and fast cells taken from the same individuals. 
As shown in Table VII, dialysis of the plasma had the effect of decreasing 
the absolute  migration rate. However,  fast cells in dialyzed fast plasma mi- MELVIN  M.  KETCHEL AND  CUTTING B.  FAVOUR  657 
grated faster (1.3 mm.) than fast cells in dialyzed slow plasma (0.7 ram.), and 
slow cells  in dialyzed fast plasma migrated faster (1.2  mm.)  than slow cells 
in  dialyzed  slow  plasma  (0.5  ram.).  Plasma  factors  controlling  leucocyte 
migration are not removed by dialysis. 
An experiment was also performed in which the cells of slow and of fast 
individuals were tested against slow and fast plasmas which had been sub- 
TABLE VII 
Average Migration Distance of Cells Cultured in Untreated and in Dial3~ed Plasmas 
Plasma 
JL untreated ...................................... 
MMK untreated ................................... 
J'L dialyzed ....................................... 
MMK dialyzed  ................................... 
J'L cells  MMK cells 
2.1  1.7 
1.1  0.7 
1.3  1.2 
0.7  0.5 
TABLE VIII 
MigroMon of Leucocyte~ in Untreated Plasma and in Plasma Healed at 56°C. for 30 Minutes 
Migration distance 
Untreated 
m~° 
1.3 
2.6 
2.4 
2.0 
2.2 
1.6 
Heated 
mm. 
0.5 
0.6 
0.8 
0.1 
0.4 
0.3 
Decrease 
lber ¢eng 
62 
77 
67 
95 
82 
81 
Average .............................................  77 
jected to a temperature of 56°C. for 30 minutes. As shown in Table VIII, this 
treatment drastically lowered the accelerating properties  of the plasma,  in- 
die.sting that the plasma factors involved in leucocyte migration are  "heat- 
labile." 
(f) Lack of Effect of Complement. e The fact that heating the plasrna to 56°C. 
for 30 minutes reduced  the  accelerating properties  of the plasma  suggested 
that complement might be involved. Attempts to increase the migration rate 
of ceils in slow plasma by the addition of guinea pig plasma, which is noted 
e The authors are indebted to Dr. Joseph J. Hoet, Peter Bent Brigham  Hospital, Boston, 
for his assistance in carrying out these experiments. 658  MIGRATION  OF  LEUCOCYTES  IN  VITRO 
for  its  high  complement  titer,  were  unsuccessful.  Furthermore,  decomple- 
menting plasma by adsorption with successive exposures to sensitized sheep 
cells did not affect the plasma migration factor. When this complement-free 
serum was then heated at 56°C. for 20 minutes, the plasma factor was destroyed. 
(g)  Fractionation  of  the  Plasma.  In  an  effort to  determine  which plasma 
proteins exerted an effect on leucocyte migration, a  series  of experiments was 
performed with plasma protein fractions. These fractions were  obtained by 
the use of the small volume, cold alcohol technique described by Lever et al. 
(1951), and modified in this laboratory by Vaughan et al.  (1955). After their 
precipitation,  the  fractions  were  redissolved  in  Hanks's  solution,  brought 
back to 1/~ the volume of the original plasma, and dialyzed for 48 hours against 
several changes of Hanks's solution. Aliquots of the fractions were then stored 
TABLE IX 
The Effect on Leucocyte  Migration of Adding Fractions of Plasma Proteins to Con~ol Plasma 
I 
Control  Control +  fraction II  Control  +  fraction III  Control  +_i f~ction IV 
mrtl. 
2.2 
2.5 
1.6 
1.7 
1.2 
0.9 
3.1 
mm° 
1.3 
1.5 
1.6 
1.4 
1.6 
0.9 
2.2 
film, 
0.4 
0.7 
1.5 
0.2 
1.7 
0.2 
0.2 
1Pron. 
1.0 
1.0 
2.1 
1.9 
2.5 
1.5 
1.5 
Average, ram. 1.9  1.5  0.7  1.6 
S.D., ram.  0.8  0.3  0.6  0.7 
at --20°C. until used. While there are many proteins present in plasma which 
are not yet described, or which are present only in traces, the  separation of 
plasma proteins, according to this technique, is stated by Lever et al. to be as 
follows:-- 
Fraction II, "),-globulin. 
Fraction  III,  ~l-lipoproteins,  /31-lipid-poor proteins,  ceruloplasmin,  isoag- 
glutinins,  plasminogen,  cold-insoluble  globulin,  prothrombin,  and  part  of 
the fibrinogen. 
Fractions  IV  and  V,  serum  albumins,  ill-metal-combining  proteins,  a2 
glycoproteins, a2 mucoprotein, al lipoprotein,  iodoproteins,  choline esterase, 
alkaline  phosphatase,  al  glycoprotein,  a2  protein,  ~l-protein,  other  small 
proteins and peptides. 
Table IX is a summary of 7 experiments in which the plasma protein frac- 
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the whole plasma of an individual with fast leucocyte migration (JL) of the 
same  blood  type  (A,  Rh+).  The  cells used  were  autologous  to  the  whole 
plasma.  The fractions were added  to  the control plasma  in amounts which 
made the final concentration of the added fraction equal to ~  of the amount 
of that fraction contained in the control plasma. It can be seen from Table IX 
that  the  addition  of fraction HI  caused  an  inhibition  of  the  migration  of 
leucocytes, while the other fractions exerted relatively little effect. The t  test 
shows that the effect of fraction III was at the 0.01 level of significance, while 
the effects of fraction II and of fraction IV +  V were not significant. 
Two  similar  experiments  were  performed  in  which  the  plasma  protein 
fractions were obtained from different sources. In one, we observed the migra- 
tion of the leucocytes of an individual (JL) when the leucocytes were migrating 
in his  own plasma  to which had been added proteins fractionated from his 
own  plasma.  In  the  second  experiment,  we  observed  the  migration  of  the 
leucocytes of an individual (J'L, type A, R_h+ blood) when the leucocytes were 
migrating in his own plasma  to which were added the proteins fractionated 
from the plasma of an individual (ES) of a different major blood group (Type 
O,  Rh+).  With  the  experiment described in  the  preceding paragraph,  this 
made a series in which the ceils and plasma were the same, but to which were 
added  plasma  protein  fractions  from  three  different  sources;  from  the  in- 
dividual's own plasma, from the plasma of a  different individual of the same 
major blood group, and from the plasma of an individual of a different major 
blood group. 
In all  of these experiments, the results were in agreement with  those re- 
corded in Table IX. 
It will be noted that fraction III acted as an inhibitor of leucocyte migration. 
But  the  above-mentioned experiments in  which  plasma  was  heated  to  56  ° 
for 30 minutes indicated that a heat-labile stimulator might be involved. No 
consistent  evidence  was  encountered in  any  of  the  plasma  fractions for  a 
factor which accelerated migration in whole plasma although in a few experi- 
ments  only fraction II  had  a  stimulatory effect. This is a  different finding 
from earlier experiments in  this  series in  which  a  heat-labile plasma  factor 
was  studied.  Further information on  this point  was  obtained  when plasma 
protein fractions were added to plasma which had previously been heated to 
60°C. for 30 minutes. The fractions were obtained either from type A, Rh+ 
or  type O,  Rh+  individuals.  In  each  experiment,  one  series  was  prepared 
with type A fractions, and one series with type O fractions. 
The results of these experiments are recorded in Table X. It can be readily 
observed that the addition of any of these plasma protein fractions caused a 
significant change in leucocyte migration. The addition of fraction III and of 
fraction IV +  V caused a decrease in migration rate. The addition of fraction 
II caused an increase in leucocyte migration.  In an effort to verify the fact 660  MIGRATION OF  LEUCOCYTES IN  VITRO 
that  the  addition of fraction II was  replacing a  stimulating factor  that had 
been destroyed by the heating of whole plasma, samples of fraction II, heated 
to 60°C.  for 30 minutes, were included in the later experiments. As indicated 
in Table X,  heated fraction  II was  not  able  to  significantly alter leucocyte 
migration when added to heated plasma. This final result indicates that  the 
TABLE X 
Effect on Leucocyte Migration of Adding  Fractions of Plasma Proteins to Control Serum wh~h 
had been heated to 60°C. for 30 M~nutes 
r 
Heated  Heated  Heated  Heated  control  control  Heated  Control  A*  control  A*  A*  control  A"  "4- frac- 
control  serum  + frac-  "-b heated  "I- frac-  tlon IV  tion II  fraction  tion III  II  + V 
mDg,  gg~$.  m~.  fn~/t.  ~m.  q~tfn.  ~B~.  fttft#,  mf~lt.  Mitt. 
1.1  1.6  0.5  1.6  0.5  1.3  --0.2  1.0 
1.5  0.4  0.8  0.3  0.8 
A* 
~tt~tL 
-0.1 
-0.3 
0.8  1.8  1.0  1.2  0.4  0.8  0.0  0.8  0.0 
1.2  0.4  0.9  --0.1  0.8  0.0 
0.7  1.1  0.4  0.8  0.1  0.3  --0.4  0.5  --0.2 
0.8  0.1  0.3  --0.4  0.5  --0.2 
0.8  1.0  0.2  1.0  0.2  0.7  --0.1  0.6  --0.2 
1.0  0.2  0.7  --0.2  0.5  --0.3 
0.5  0.7  0.2  0.4  --0.1  0.4  --0.1  0.6  --0.2  0.3  --0.2 
0.7  0.2  0.6  0.1  0.3  --0.2  0.4  --0.1 
1.5  2.7  1.2  1.9  0.4  1.4  --0.1  1.3  --0.2  1.2  --0.3 
2.3  0.8  1.7  0.2  1.4  --0.1  1.0  --0.5 
Mean..  0.6  0.3  0.02  -0.2  -0.2 
s.D.  0.42  0.2  0.17  0.2  0.14 
s.z.M.  0.17  0.06  0.09  0.06  0.04 
Mean/s.E.M 
(C.R.)  3.5  5.0  --  5.3  5.0 
* Difference between heated control, and heated control with fraction added. 
accderator in fraction II is characterized by the same heat lability as that in 
whole plasma. 
These experiments demonstrate the presence in the plasma of at least two 
factors which regulate leucocyte migration; a  heat-labile accelerator found in 
fraction II and an inhibitor found in fraction III. 
DISCUSSION 
In  the  experiments  described  above,  a  single  aspect  of  the  physiology of 
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leucocyte migration.  Whether  enhanced  migration  is  correlated  with  other 
functions of leucocytes is not the subject of this report. Present evidence in- 
dicates that the host possesses a homeostatic humoral mechanism,  consisting 
of an inhibitor and a stimulator, which during some types of stress may cause 
wide fluctuations in the migratory rate of leucocytes. 
The major factors which influence leucocyte migration are contained in the 
plasma (Table V). Under the conditions of these experiments the cells them- 
selves  account  for  some of  the  difference  in  migration  distance  among  in- 
dividuals.  Stated  briefly, fast cells  in slow plasma migrate faster than  slow 
cells in slow plasma,  and slow cells in fast plasma migrate  slower  than  fast 
cells in fast plasma.  It  may be that  washing  leucocytes completely free of 
adsorbed  or ingested plasma  is impossible,  especially after  they have  been 
subjected to repeated mild trauma.  Perhaps "washed" cells are,  to a  certain 
extent, still under the influence of traces of the plasma from which  they were 
taken. Cell factors may be due to other causes as well. 
C-reactive protein,  which  appears in  the plasma  of individuals in  disease 
states, and is not ordinarily present in the plasma of normal individuals,  was 
reported by Wood (1951) to increase  leucocyte migration.  We have confirmed 
the essentials  of his results. Using our capillary tube technique, high  concen- 
trations of C-reactive protein  ~ inhibit leucocyte migration. Optimal concentra- 
tions stimulate leucocyte migration 30 to 40 per cent.  Since normal subjects 
do not possess detectable amounts of C-reactive protein in  their  blood, the 
plasma factor of this study does not appear to be the same phenomenon de- 
scribed by Wood. 
Menkin (1950) has postulated the existence of a leucocyte-promoting factor 
(LPF), thought to be a globulin or polypeptide, derived from tissue exudates. 
According  to Menkin, this factor is present only where tissue exudates occur. 
It is doubtful that LPF bears any relation to the plasma factors here described. 
In a  study of the migration  of leucocytes from an explant,  Allgower  and 
Sullman  (1950) found  that  diminished  migration  takes  place  in  Tyrode's 
solution alone whereas plasma proteins alter cell migration.  By the use of a 
salting-out  technique,  they divided  the plasma  proteins  into  two fractions, 
the y-globulins and the "rest-proteins." When the 3,-globulins were added to 
the Tyrode's solution,  it was found that  the leucocytes migrated away from 
the explant to a much greater degree than when they were in Tyrode's alone, 
or in Tyrode's plus the "rest-proteins." It was also found that the -y-globulins 
exerted a positive chemotactic effect on leucocytes. Taken together with our 
finding  that fraction II, which  contains the T-globulins,  enhanced the migra- 
tion of leucocytes, these results strongly suggest that  the h'-globulins  have a 
function in  disease  resistance  beyond that  associated with antigen-antibody 
reactions. 
C-reactive  protein  for these  experiments was kindly supplied  by Dr. Harrison F. Wood 
of the Hospital of The Rockefeller  Institute,  New York. 662  MIGRATION  O1~' LEUCOCYTES IN  VITRO 
The utilization of this in vitro  technique has provided an  opportunity to 
investigate  the  effects of  plasma  in  the  regulation  of  leucocyte migration. 
While the conditions inside a capillary tube are unlike those in the living host, 
it  is  quite  likely  that  this  laboratory procedure  accurately reflects in  vivo 
mechanisms controlling the rate of leucocyte migration. Further work will be 
necessary to determine the extent to which this plasma system controls other 
functions of leucocytes, and  whether it  is  important  in  the pathogenesis of 
disease processes involving leucocytes. 
SUMMARY 
A new method is described for the quantitative study of leucocyte migration. 
Blood drawn into a  capillary tube is centrifuged, forming a  buffy coat. The 
migration of the leucocytes from the buffy coat into the plasma is measured 
by means of an ocular micrometer. 
While there is a  great deal of variation from one normal individual to an- 
other in the migration rates of leucocytes those of each individual show rela- 
tively little variation in migration from day to day (Table I). 
In all cases of illness studied,  the average migration rates fall within the 
normal range, but there was a  wider variation in the day to day migration 
rate than obtains in normal healthy individuals (Tables II and Ill). 
From  experiments  in  which  the  cells  with  typically  "slow"  and  "fast" 
migration rates were tested in both the "slow" and "fast" plasmas,  it could 
be concluded that while the cells invariably have some influence on the migra- 
tion  rate,  the  major  factors  influencing  leucocyte  migration  reside  in  the 
plasma (Table V). 
Experiments in which the plasma proteins were fractionated according to 
the method of Lever et aI. indicated the presence of a system of proteins which 
regulate leucocyte migration. A heat-labile (56°C. for 30 minutes) component 
of fraction II was able  to accelerate leucocyte migration,  while fraction III 
acted as an inhibitor (Tables IX and X). 
Doctors John F. Hanks, Harvard Medical School, Boston, Dr. Howard A. Schneiderman, 
Comell University, Ithaca, Drs. Mary A. Teller and William H. Teller, University of Penn- 
sylvania, Philadelphia, Dr. Harrison F. Wood, of the Hospital of The Rockefeller  Institute, 
New York, and Professor Carroll M. Williams, Harvard  University, Cambridge,  were most 
helpful in reading this paper in manuscript form. We would also like to thank the members 
of the Department of Biostatistics of the Harvard School  of Public Health, Boston, for their 
help and advice on statistical procedures. 
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